Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.49% |
| 2 | Energy | 5.29% |
| 3 | Technology | 4.48% |
| 4 | Financials | 3.44% |
| 5 | Consumer Discretionary | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAL
5076
CALL
DELISTED
Valspar
VAL
| $117K | ﹤0.01% |
+1,500
| New | +$118K |
|
|
VAL
5077
PUT
DELISTED
Valspar
VAL
| $117K | ﹤0.01% |
+1,500
| New | +$118K |
|
5078
Rollins
ROL
$17.4B
| $116K | ﹤0.01% |
13,554
-21,522
| -61% | -$188K |
|
5079
ANI Pharmaceuticals
ANIP
$1.72B
| $115K | ﹤0.01% |
4,116
+3,588
| +680% | +$108K |
|
5080
PUT
Exelixis
EXEL
$12.5B
| $115K | ﹤0.01% |
115,600
+32,400
| +39% | +$104K |
|
|
ECHO
5081
CALL
EchoStar
ECHO
$26.6B
| $115K | ﹤0.01% |
2,962
-987
| -25% | -$40.5K |
|
|
ECHO
5082
PUT
EchoStar
ECHO
$26.6B
| $115K | ﹤0.01% |
2,962
-987
| -25% | -$40.5K |
|
|
MDRX
5083
DELISTED
Veradigm Inc. Common Stock
MDRX
| $115K | ﹤0.01% |
8,785
-54,086
| -86% | -$820K |
|
|
RGP
5084
PUT
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
| $115K | ﹤0.01% |
3,600
+400
| +13% | +$12.7K |
|
5085
Ezcorp Inc
EZPW
$1.78B
| $114K | ﹤0.01% |
12,744
-18,085
| -59% | -$188K |
|
5086
CALL
ITT
ITT
$19.4B
| $114K | ﹤0.01% |
2,600
-4,700
| -64% | -$224K |
|
5087
Semtech
SMTC
$12.4B
| $114K | ﹤0.01% |
4,203
-5,704
| -58% | -$144K |
|
5088
VanEck Intermediate Muni ETF
ITM
$2.14B
| $113K | ﹤0.01% |
2,442
+582
| +31% | +$27.2K |
|
5089
Lithia Motors
LAD
$8.32B
| $113K | ﹤0.01% |
1,518
+64
| +4% | +$5.66K |
|
5090
PUT
Madison Square Garden
MSGS
$9.97B
| $113K | ﹤0.01% |
2,383
-1,262
| -35% | -$56.9K |
|
5091
PUT
Olin
OLN
$2.17B
| $113K | ﹤0.01% |
4,500
+2,500
| +125% | +$66.5K |
|
|
SPPI
5092
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $113K | ﹤0.01% |
14,100
+10,300
| +271% | +$80.6K |
|
|
RBCN
5093
DELISTED
Rubicon Technology, Inc.
RBCN
| $113K | ﹤0.01% |
2,829
+2,455
| +656% | +$168K |
|
|
TRQ
5094
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $113K | ﹤0.01% |
3,760
-360
| -9% | -$12.7K |
|
|
CAVM
5095
PUT
DELISTED
Cavium, Inc.
CAVM
| $113K | ﹤0.01% |
2,300
+200
| +10% | +$10.1K |
|
5096
PUT
BOK Financial
BOKF
$8.85B
| $112K | ﹤0.01% |
+1,700
| New | +$113K |
|
|
PBT
5097
PUT
Permian Basin Royalty Trust
PBT
$1.56B
| $112K | ﹤0.01% |
8,600
+2,200
| +34% | +$30.9K |
|
5098
Televisa
TV
$1.49B
| $112K | ﹤0.01% |
3,369
-49,147
| -94% | -$1.75M |
|
5099
UMB Financial
UMBF
$11.4B
| $112K | ﹤0.01% |
2,062
+1,381
| +203% | +$79.7K |
|
5100
Wolverine World Wide
WWW
$1.63B
| $112K | ﹤0.01% |
4,532
+2,561
| +130% | +$66K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 5% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.